2015 American Transplant Congress
Preemptive Therapy for Cytomegalovirus Disease in Liver Transplant Recipients-A Single Center Experience
1Rush University Medical Center, Chicago, IL; 2Lahey Hospital and Medical Center, Boston, MA.
Background: Cytomegalovirus (CMV) is a common opportunistic infection after liver transplantation and is associated with significant morbidity and mortality. There are two strategies for preventing…2015 American Transplant Congress
Interventional Treatment With Minimal Surgery Is an Effective Way for Acute Portal Vein Thrombosis After Pediatric Liver Transplantation: The Experience of Largest Pediatric Liver Transplantation Center in China
Purpose: The purpose of this study was to evaluate the prognosis of interventional treatment through inferior mesenteric vein (IMV) and other treatments systemically for acute…2015 American Transplant Congress
Efficacy of Low Dose Chemoprophylaxis for Coccidioidomycosis Infection in Liver Transplantation Recipients
Introduction:Coccidioidomycosis(CM) infection rate of 6.9% has been reported in solid organ transplantation recipients living in endemic Southwestern U.S.Aim:Assess the risk of CM infection in liver…2015 American Transplant Congress
The Extended Toronto Criteria for Transplantation for Hepatocellular Carcinoma. A Validation Study
Multi-Organ Transplant, Toronto General Hospital. University of Toronto, Toronto, ON, Canada.
Liver transplant (LT) listing criteria for patients with hepatocellular cancers (HCC) that exceed the Milan criteria are still controversial. At the University of Toronto, we…2015 American Transplant Congress
Changes in Acceptances Patterns Under Share 35
University of Texas HSC, San Antonio, TX; UNOS, Richmond, VA.
The Share 35 policy was implemented June 2013 with intent of directing to livers to the sickest patients with the highest mortality and presumably shortest…2015 American Transplant Congress
High Tolerability With Sofosbuvir-Based Direct-Acting Antiviral Therapy in Liver Transplant Recipients With Recurrent Hepatitis C
Background: Reports on efficacy, safety, and tolerability of sofobuvir-based antiviral regimens in liver transplant recipients with recurrent hepatitis C are limited. Methods: We performed a…2015 American Transplant Congress
Plasmapharesis, Intravenous Immunoglobulin and Rituximab Successfully Treat Recurrent Progressive Familial Intrahepatic Cholestasis Type 2 (PFIC-2) After Liver Transplantation
Background:Allo-immune mediated BSEP dysfunction may occur after liver transplantation in PFIC2 patients leading to a PFIC2 like phenotype. The IgG antibodies are reactive toward a…2015 American Transplant Congress
Pre-Liver Transplant Urinary Proteome Analysis Does Not Predict Development of Chronic Kidney Disease After Transplantation
Background and aims: Chronic kidney disease (CKD) is a common complication after liver transplantation. Kidney biopsies cannot be easily performed before liver transplantation to predict…2015 American Transplant Congress
Epidemiology of Early Post Liver Transplant (LT) Infections 2008-12: Time to Reconsider Perioperative Prophylaxis Regimen?
Department of Medicine, University of Alberta, Edmonton, AB, Canada.
Background: The most common pathogens seen in early post LT intraabdominal and bloodstream infection are enterococci, staphylococci and aerobic gram negative bacilli and perioperative prophylaxis…2015 American Transplant Congress
Utilization of Liver Allografts from Deceased Donors. Non Medical Causes for Discard. A Review of the SRTR Annual Report
1Surgery, Porter Adventist Hospital, Denver, CO; 2Medicine, Porter Adventist Hospital, Denver, CO.
INTRODUCTION: Discrepancy between demand (end stage organ disease) and supply (organs) remains one of the limiting factors in solid organ transplantation and underlies the dynamics…
- « Previous Page
- 1
- …
- 170
- 171
- 172
- 173
- 174
- …
- 180
- Next Page »